78
Participants
Start Date
September 30, 2025
Primary Completion Date
June 1, 2027
Study Completion Date
June 1, 2027
The initial pain assessment
The initial pain assessment will be carried out according to pain assessment scales in children adapted to the patient's age and cognitive abilities (NRS, FLACC).
Drug administration according to protocol (paracetamol + ibuprofen OR paracetamol + metamizol)
"Group A will receive a dose of Paracetamol B. Braun/Paracetamol Kabi intravenously 15 mg/kg body weight (maximum 1000 mg/dose) and Ibuprofen B.Braun/Ibuprofen Kabi intravenously 10 mg/kg body weight (maximum 400 mg/dose).~Group B will receive a dose of Paracetamol B. Braun/Paracetamol Kabi intravenously 15 mg/kg body weight (maximum 1000 mg/dose) and Metamizol-SF/Metamizole Kabi/Pyralgin intravenously 15 mg/kg body weight (maximum 100 mg/dose)."
The effectiveness of the treatment
The effectiveness of the treatment will be assessed 60 minutes after the start of the intervention according to pain assessment scales in children adapted to the patient's age and cognitive abilities (NRS, FLACC).
RECRUITING
Department of Paediatric Gastroenterology and Nutrition, Warsaw
Medical University of Warsaw
OTHER